Tysabri (Natalizumab)

Tysabri (Natalizumab) is a drug used to treat relapsing multiple sclerosis (MS) to reduce the frequency of flare-ups and delay progression of physical disability and Crohn’s disease in adults. The drug is known to cause serious brain infections (PML) and liver toxicity.